Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs UFH with Thrombolysis in Massive PE
NCT01956955Phase 4Unknown
- Sponsor
- Atatürk University
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in pulmonary embolism (PE), sponsored by Atatürk University. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01956955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956955.